Posts Tagged ‘Hemophilia’

OBI-1 Developed By Ipsen And Inspiration Has Obtained A Positive Opinion For The Orphan Drug Status In Europe

Category:

Uncategorized

Tagged with:

Share it:

Commentary: Why We Need Better Drug Monitoring

Category:

Uncategorized

Tagged with:

Share it:

Irish Government Launches Program To Provide Life Insurance To People With HIV, Hepatitis C Through Contaminated Blood Products

Category:

Uncategorized

Tagged with:

Share it:

Biogen Idec And Swedish Orphan Biovitrum Announce First Patient Dosed In Global Registrational Trial Of Long-Acting Hemophilia B Therapy

Category:

Uncategorized

Tagged with:

Share it:

Ipsen’s Partner Inspiration Biopharmaceuticals Announces Non-Inferiority Of IB1001, Its Recombinant Factor IX For Hemophilia B

Category:

Uncategorized

Tagged with:

Share it:

New Data To Be Presented At The World Federation Of Hemophilia 2010 Congress

Category:

Uncategorized

Tagged with:

Share it:

The Product Portfolio Strategy As Decisive Force In Forming The Future Coagulation Factor Market

Category:

Uncategorized

Tagged with:

Share it:

Helixate FS Receives FDA Approval For Routine Prophylaxis In Children With Hemophilia A

Category:

Uncategorized

Tagged with:

Share it:

Beriplex® P/N Provides Fast, Predictable And Safe Anti-Coagulation Reversal, According To Study

Category:

Uncategorized

Tagged with:

Share it:

PTC Therapeutics Initiates Phase 2 Clinical Trial Of Ataluren (PTC124(R)) In Patients With Hemophilia

Category:

Uncategorized

Tagged with:

Share it:

Tag Cloud